If successfully integrated, CD146 could help personalize HF care by refining diagnosis, enhancing prognostication, and guiding decongestive management, ultimately aligning with the goals of precision medicine in cardiovascular disease [1]. This evidence concerns the gene MCAM and cardiovascular disorder.